The morning guidelines sessions at the 2026 Congress of Neurological Surgeons Annual Meeting in Washington, DC represent a pivotal opportunity for the neurosurgical community to engage with the latest evidence-based recommendations shaping clinical practice. This year’s sessions reflect the breadth and depth of the CNS Guidelines Committee’s ongoing work, spanning spinal surgery, neurotrauma, functional neurosurgery, and more. They underscore the commitment of the CNS to producing rigorous, transparent, and impactful guideline development.
Featured Guidelines at the Annual Meeting
Several highly anticipated guidelines are slated for presentation at this year’s Annual Meeting, each addressing critical, high-priority clinical questions. The Traumatic Brain Injury Transfer Practice Parameter offers updated evidence-based recommendations for the safe and efficient triage of patients with brain injury, a topic that is especially critical given continued disparities in access to care. The Spine Metastases guidelines update reflects the rapidly evolving landscape of neuro-oncology, incorporating an extensive body of literature and leveraging artificial intelligence (AI) for systematic data extraction. In addition, comprehensive Lumbar Fusion guidelines will be presented to address the evolving spine surgery landscape and its clinical implications.
Additionally, updates on topics including plagiocephaly, craniopharyngiomas, and return to physical activity after spinal surgery address common questions that arise in daily practice. These highlight just a fraction of the guideline output this year, with several major updates, including epilepsy and cervical degenerative disease, also in development.
The Guidelines Development Process
Each of the guidelines presented at the CNS Annual Meeting is the culmination of significant work from a dedicated task force composed of subspecialty experts, Guidelines Fellows, and members of the Guidelines Committee. These task forces evaluate evidence using standardized methodologies and draft recommendations that undergo rigorous review by the Joint Guidelines Review Committee (JGRC).
2026 marks a historic milestone in CNS guidelines methodology with the formal integration of artificial intelligence. Currently piloted in the Spine Metastases project, AI-assisted data extraction is demonstrating the potential to drastically accelerate systematic review timelines without compromising the stringent rigor essential to evidence-based medicine. To safeguard this process, the CNS has proactively established an AI subcommittee and formalized strict disclosure policies with Neurosurgery regarding AI use in guideline development, demonstrating its commitment to transparency.
Impact of Guidelines
Guidelines have become increasingly important in practice and reimbursement, which is why they have long been a cornerstone of the CNS educational mission. The CNS has invested in expanding access to each guideline through innovative digital channels. The guidelines podcast series, hosted by Brad Elder, has now surpassed 45,000 listens, a milestone that reflects the community’s appetite for accessible, high-quality clinical guidance. Furthermore, ongoing updates to the CNS website and the integration of dynamic AI features within the CNS+ app have created new ways for users to interact with these documents.
The 2026 Program and Guidelines Committee continues to expand its efforts and tackle new initiatives, with more than 20 active projects in various stages of development. Upcoming topics include trigeminal neuralgia, acute cervical spine injury, and spinal cord stimulation. The committee is also continuing to build on prior external collaborations, including partnerships with the American Society of Clinical Oncology (ASCO), the Bobby Jones CSF Foundation, North American Neuromodulation Society (NANS), and the Brain Trauma Foundation (BTF).
Ultimately, the guidelines sessions at the Annual Meeting are more than a reporting mechanism, they are a living forum for continued growth and improvement. We encourage you to not only attend these sessions, but also engage actively in the discussions that shape the future of evidence-based neurosurgical care.
